IOBT vs LMT · $98.2M cap vs P/E 20, rev $20.06B
IO Biotech Inc (IOBT) versus Lockheed Martin Corporation (LMT) — a side-by-side from cached financials, not a winner call.
IO Biotech Inc (IOBT) is a biotechnology company listed on US.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
IOBT does not have a complete income-statement cache yet.
Latest reported LMT revenue for 2026-06-28 was $20.06B. Net income was $1.84B. Revenue was up 11.3% from 2026-03-29 to 2026-06-28. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
IOBT currently screens at market cap $98.2M. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Not investment advice. Open the IOBT and LMT stock pages for the full models.
Not investment advice.